All In MedTech

Device Trial Radar · NCT07946237

Optimizing Cough Rehabilitation Through Combined Cough Skill Training and Transcutaneous Spinal Cord Stimulation

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

16

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Sep 30, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
University of FloridaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
American Speech-Language-Hearing Foundation
First posted
Nov 18, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 40 years, up to 85 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to evaluate the effects of combining cough training with low-level electrical stimulation to the neck (tsDCS) in healthy adults and adults with neurological diseases. The main questions it aims to answer are: * Is using tsDCS during cough training safe, tolerable, and acceptable to participants? * What tsDCS settings are most effective for pairing with cough training? Researchers will compare sham stimulation with active tsDCS to see if tsDCS enhances cough gains. Before and after each testing session, participants will complete breathing, coughing, and respiratory-strength training.

Conditions

  • Healthy Adult
  • Rehabilitation Exercise
  • Electric Stimulation Therapy
  • Cough Peak Flow
  • Ventilatory Function

Interventions

  • transcutaneous spinal direct current stimulationDevice

    Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes.

  • Cough Skill TrainingBehavioral

    CST involves visual feedback on a computer screen to guide participants through coughing at specific target ranges (strong, moderate, and weak).

  • Sham stimulationDevice

    Transcutaneous spinal cord stimulation at reduced intensity, lasting 1 minute at the beginning and end of a 20-minute session.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Completion of training tasks with simultaneous stimulationTime frame: During training
  2. Peak Cough FlowTime frame: Baseline, immediate post-single-treatment measurement

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Florida

    Gainesville, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.